Our Commitment to Serious Disease

In each of our therapeutic areas, we are at the forefront of developing education and public policy initiatives to ensure that patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care.

Millions of Americans live with serious, life-altering diseases. At Janssen Biotech, Inc. we dedicate our hearts and minds to improving the health of these individuals in three distinct areas where the burden is great:

IMMUNOLOGY

• Dermatology
  • Plaque Psoriasis
• Gastroenterology
  • Crohn's Disease
  • Ulcerative Colitis
• Rheumatology
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis

ONCOLOGY

• Anemia Due to Concomitant Myelosuppressive Chemotherapy in Patients with Cancer
• Relapsed or Refractory Multiple Myeloma
• Recurrent Ovarian Cancer
• Metastatic Castration-Resistant Prostate Cancer after Docetaxel

NEPHROLOGY

• Anemia Due to Chronic Kidney Disease in Patients Not on Dialysis

OTHER SUPPORTED CONDITIONS

• Reduction of Red Blood Cell Transfusions in Patients Undergoing Elective, Noncardiac, Nonvascular Orthopedic Surgery
• Anemia Due to Zidovudine in HIV-infected Patients

We believe that changing lives for the better takes more than medicine.